| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 6.7% | -14.4% |
| ROCE | 7.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 81.6 | n/a |
| PEG | 2.8 | n/a |
| Pr/Revenue | 6.2 | 6.1 |
| Pr/Book | 5.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 0.2% | 1.6% |
| PBT | 2.0% | n/a |
| EPS | 28.9% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-07 | 1.36 | (1.20) | (22.40)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-08 | 2.07 | (1.33) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-09 | 3.97 | (0.67) | 1.10p | 309.1 | n/a | n/a | n/a | 0.0% |
| 30-Jun-10 | 5.74 | 0.35 | 3.80p | 92.8 | 0.4 | +246% | n/a | 0.0% |
| 30-Jun-11 | 5.75 | 0.36 | 4.90p | 77.0 | 2.7 | +29% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-12 | 5.84 | (0.84) | (9.32)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-13 | 7.06 | (0.20) | (2.81)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 02-May-2012 | 08:42 | RNS |
| Director/PDMR Shareholding | 03-Apr-2012 | 16:53 | RNS |
| Additional Listing | 27-Mar-2012 | 09:13 | RNS |
| Big things expected of EpiStem's Genedrive device | 11-Oct-2011 | ShareCast |
| Epistem sees solid growth | 29-Mar-2011 | ShareCast |
| Maiden pre-tax profit for Epistem | 05-Oct-2010 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 400.00p |
| Change Today | -2.50p |
| % Change | -0.62 % |
| 52 Week High | 422.50p |
| 52 Week Low | 352.50p |
| Volume | 3,970 |
| Shares Issued | 8.85m |
| Market Cap | £35.40m |
| Beta | 0.05 |
| RiskGrade | 52 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 14:06 | 700 @ 395.00p |
| 13:05 | 3,270 @ 380.00p |
| CEO | Matthew Walls |
| Finance Director | John Rylands |
You are here: research